Cincinnati Startup Raises $50 Million to Advance Hypertension Treatment Licensed from Roche

Posted on June 13, 2019 by gracelukich in Companies // 0 Comments

Cincinnati-based CinCor Pharma snagged $50 million in Series A financing, as well as rights to a Roche therapy for treatment-resistant hypertension and primary aldosteronism, a hormonal disorder that can lead to high blood pressure.

Click here to read the complete article.

Story excerpt provided by BioSpace.

Written by Alex Keown.

Originally published May 15, 2019.

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Google photo

You are commenting using your Google account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

Copyright © 2019 Blog at WordPress.com.

%d bloggers like this: